ANXA1 and chronic obstructive pulmonary disease: In particular, for sRAGE (sensitivity = 96.6%; specificity = 0.975%, p < 0.001), regarding annexin A1, the results suggested a cut-off value of 10.7 ng/mL with 91.67% sensitivity and 82.50% specificity between the COPD patient group and the control group.